PHS
CNC icon

PFM Health Sciences’s Centene CNC Stock Holding History

PFM Health Sciences’s Portfolio CNC Stock Details CNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-372,300
Closed -$15.3M – 86
2025
Q4 		$15.3M Buy
+372,300
New +$13.9M 1.53% 23
2021
Q3 		– Sell
-225,000
Closed -$16.4M – 91
2021
Q2 		$16.4M Buy
+225,000
New +$15.4M 0.51% 53
2017
Q4 		– Sell
-1,432,600
Closed -$69.3M – 82
2017
Q3 		$69.3M Buy
+1,432,600
New +$61.7M 1.36% 26

Other funds holding CNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PFM Health Sciences's CNC Position: Q1 2026 in Review

PFM Health Sciences reduced its Centene (CNC) stake by 64% in Q1 2026, selling an estimated $18.9M and leaving 263,486 shares worth $8.63M. The position accounts for 0.79% of the portfolio, ranked #41.

PFM Health Sciences first reported a position in CNC in Q3 2014 and has held it in 26 quarters since. The position peaked at $94.1M in Q2 2022. 862 funds tracked by Wall St. Rank hold CNC as of Q1 2026.

  • PFM Health Sciences held 263,486 shares of Centene worth $8.63M as of Q1 2026.
  • PFM Health Sciences sold 461,938 Centene shares in Q1 2026, an estimated $18.9M.
  • Centene made up 0.79% of PFM Health Sciences's portfolio in Q1 2026, its #41 holding.
  • PFM Health Sciences first reported a position in Centene in Q3 2014 and has held it in 26 quarters since.
  • PFM Health Sciences's Centene position peaked at $94.1M in Q2 2022.
  • 862 funds tracked by Wall St. Rank held Centene as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.